Teladoc Health Book Value Per Share Growth & History (TDOC)
Teladoc Health's book value per share was $7.77 for fiscal 2025.
View full Teladoc Health company overviewTeladoc Health annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $7.77 | -$0.83 | −9.63% |
| 2024 | 2024-12-31 | $8.60 | -$5.36 | −38.39% |
| 2023 | 2023-12-31 | $13.96 | -$0.21 | −1.51% |
| 2022 | 2022-12-31 | $14.17 | -$85.82 | −85.83% |
| 2021 | 2021-12-31 | $99.99 | -$5.70 | −5.39% |
| 2020 | 2020-12-31 | $105.69 | $91.76 | +658.41% |
| 2019 | 2019-12-31 | $13.94 | -$0.43 | −3.00% |
| 2018 | 2018-12-31 | $14.37 | $5.28 | +58.18% |
| 2017 | 2017-12-31 | $9.08 | $4.09 | +81.76% |
| 2016 | 2016-12-31 | $5.00 | $0.36 | +7.81% |
| 2015 | 2015-12-31 | $4.64 | $37.77 | — |
| 2014 | 2014-12-31 | -$33.14 | $12.23 | — |
| 2013 | 2013-12-31 | -$45.37 | — | — |
Teladoc Health quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $7.21 | -$0.84 | −10.43% |
| Q1 2026 | 2026-03-31 | $7.41 | -$0.73 | −9.00% |
| Q4 2025 | 2025-12-31 | $7.77 | -$0.83 | −9.63% |
| Q3 2025 | 2025-09-30 | $7.85 | -$0.92 | −10.48% |
| Q2 2025 | 2025-06-30 | $8.05 | -$0.73 | −8.26% |
| Q1 2025 | 2025-03-31 | $8.14 | -$5.38 | −39.80% |
| Q4 2024 | 2024-12-31 | $8.60 | -$5.36 | −38.39% |
| Q3 2024 | 2024-09-30 | $8.77 | -$5.09 | −36.72% |
| Q2 2024 | 2024-06-30 | $8.78 | -$5.14 | −36.94% |
| Q1 2024 | 2024-03-31 | $13.52 | -$0.46 | −3.28% |
| Q4 2023 | 2023-12-31 | $13.96 | -$0.21 | −1.51% |
| Q3 2023 | 2023-09-30 | $13.86 | -$23.46 | −62.87% |
| Q2 2023 | 2023-06-30 | $13.92 | -$23.66 | −62.96% |
| Q1 2023 | 2023-03-31 | $13.98 | -$42.66 | −75.32% |
| Q4 2022 | 2022-12-31 | $14.17 | -$85.82 | −85.83% |
| Q3 2022 | 2022-09-30 | $37.32 | -$62.60 | −62.65% |
| Q2 2022 | 2022-06-30 | $37.58 | -$62.76 | −62.54% |
| Q1 2022 | 2022-03-31 | $56.63 | -$45.89 | −44.76% |
| Q4 2021 | 2021-12-31 | $99.99 | -$5.70 | −5.39% |
| Q3 2021 | 2021-09-30 | $99.91 | $73.47 | +277.79% |
| Q2 2021 | 2021-06-30 | $100.34 | $83.97 | +512.94% |
| Q1 2021 | 2021-03-31 | $102.52 | $89.02 | +659.29% |
| Q4 2020 | 2020-12-31 | $105.69 | $91.76 | +658.41% |
| Q3 2020 | 2020-09-30 | $26.45 | $12.71 | +92.57% |
| Q2 2020 | 2020-06-30 | $16.37 | $2.43 | +17.45% |
| Q1 2020 | 2020-03-31 | $13.50 | -$0.51 | −3.66% |
| Q4 2019 | 2019-12-31 | $13.94 | -$0.43 | −3.00% |
| Q3 2019 | 2019-09-30 | $13.73 | -$0.94 | −6.41% |
| Q2 2019 | 2019-06-30 | $13.94 | $3.06 | +28.15% |
| Q1 2019 | 2019-03-31 | $14.01 | $5.17 | +58.45% |
| Q4 2018 | 2018-12-31 | $14.37 | $5.28 | +58.18% |
| Q3 2018 | 2018-09-30 | $14.68 | $6.82 | +86.92% |
| Q2 2018 | 2018-06-30 | $10.88 | $3.59 | +49.23% |
| Q1 2018 | 2018-03-31 | $8.84 | $2.53 | +40.00% |
| Q4 2017 | 2017-12-31 | $9.08 | $4.09 | +81.76% |
| Q3 2017 | 2017-09-30 | $7.85 | $2.59 | +49.14% |
| Q2 2017 | 2017-06-30 | $7.29 | $3.37 | +85.82% |
| Q1 2017 | 2017-03-31 | $6.32 | $2.05 | +48.12% |
| Q4 2016 | 2016-12-31 | $5.00 | $0.36 | +7.81% |
| Q3 2016 | 2016-09-30 | $5.26 | $0.26 | +5.10% |
| Q2 2016 | 2016-06-30 | $3.92 | $28.01 | — |
| Q1 2016 | 2016-03-31 | $4.27 | — | — |
| Q4 2015 | 2015-12-31 | $4.64 | $37.77 | — |
| Q3 2015 | 2015-09-30 | $5.01 | — | — |
| Q2 2015 | 2015-06-30 | -$24.09 | — | — |
| Q4 2014 | 2014-12-31 | -$33.14 | — | — |
Teladoc Health book value per share trends
Over the last five fiscal years, Teladoc Health's book value per share decreased from $105.69 to $7.77, a change of -$97.92. The latest reported quarter, Q2 2026, shows $7.21.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Teladoc Health source filings ↗